Keywords: CAF; Cook Agronomy Farm; CRIM; complex refractive index model; RMSE; Root Mean Squared Error; RMSEadj; Adjusted Root Mean Squared Error; SEL; standard error of laboratory measurements;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: APC; argon plasma coagulation; BE; Barrett's esophagus; CRIM; complete remission of intestinal metaplasia; DBE; dysplastic Barrett's esophagus; EAC; esophageal adenocarcinoma; GEJ; gastroesophageal junction; HGD; high-grade dysplasia; IM; intestinal m
Keywords: CK; Creatinine kinase; CRIM; Cross-reactive immunologic material; ERT; Enzyme-replacement therapy; GAA; Acid α-glucosidase; IOPD; Infantile-onset Pompe disease; LVMI; Left ventricular mass index; MRI; Magnetic resonance imaging; NBS; Newborn screening; P
Keywords: BE; Barrett's esophagus; CI; confidence interval; CRIM; complete remission of intestinal metaplasia; HGD; high-grade dysplasia; Ps-PDT; porfimer sodium photodynamic therapy; RFA; radiofrequency ablation; RR; relative risk;
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease
Keywords: ERT; enzyme replacement therapy; rhGAA; recombinant human acid-α-glucosidase; CRIM; cross-reactive immunologic material; HSAT; high and sustained antibody titer; MTX; methotrexate; SVP-Rapa; synthetic vaccine particles carrying rapamycin; NP; empty nanop
Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease
Keywords: 6MWT; 6-minute walk test; AE; adverse event; CI-MPR; cation-independent mannose-6-phosphate receptor; CK; creatine kinase; CRIM; cross-reactive immunologic material; ERT; enzyme replacement therapy; GAA; acid alpha-glucosidase; Glc4; glucose tetrasacchari
Original articleLongitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease
Keywords: Infantile-onset Pompe disease; Speech disorder; Articulation disorder; Hypernasality; Speech intelligibility; Enzyme replacement therapy; AROM; active range of motion; CRIM; cross-reactive immunologic material; ERT; enzyme replacement therapy; FEES; fiber
Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes
Keywords: AST; Aspartate aminotransferase; Bayley-III; Bayley Scale of Infant and Toddler Development, Third Edition; CK; Creatine kinase; CRIM; Cross-reactive immunologic; ERT; Enzyme-replacement therapy; GAA; Acid α-glucosidase; IOPD; Infantile-onset Pompe disea
Novel GAA sequence variant c.1211 A > G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease
Keywords: 4-MU; 4-methylumbelliferone; A; adenosine; AO; adult onset; Asp; aspartic acid; Arg; arginine; C; cytidine; cDNA; DNA complementary to RNA; CON; control(s); CK; creatine kinase; CRIM; cross-reactive immunologic material; Cys; cysteine; ERT; enzyme replace
Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry
Keywords: ACP; acid phosphatase; CRIM; cross-reactive immunologic material; DBS; dried blood spot; ECG; electrocardiogram; ERT; enzyme replacement therapy; GAA; acid alpha-glucosidase; IRB/EC; Institutional Review Board or Ethics Committee; MRI; magnetic resonance
B-Cell Depletion and Immunomodulation before Initiation of Enzyme Replacement Therapy Blocks the Immune Response to Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease
Keywords: Ab; Antibody; CRIM; Cross-reactive immunologic material; ERT; Enzyme replacement therapy; GAA; Acid alpha-glucosidase; IV; Intravenous; IVIG; Intravenous immunoglobulin; LVMI; Left ventricular mass index;
Temporal GPR imaging of an ethanol release within a laboratory-scaled sand tank
Keywords: GPR; Ethanol; Biofuels; Brilliant Blue; CRIM
Efficacy of a two-session program of cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse: A pilot study
Keywords: Posttraumatic stress disorder; Childhood sexual abuse; Cognitive therapy; Imagery modification; Disgust; CRIM; Cognitive Restructuring and Imagery Modification; CSA; childhood sexual abuse; FBC; feeling of being contaminated; PTSD; posttraumatic stress di
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
Keywords: Pompe disease; Glycogen storage disease; Enzyme replacement therapy; Lysosomal storage disease; Acid alpha glucosidase; GAA; Cross-reactive immunologic material; CRIM; Antibody
The Brazilian Consensus on the Management of Pompe Disease
Keywords: ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; CK; Creatinine kinase; CK-MB; Creatinine kinase MB isoenzyme; CRIM; Cross-reactive immunologic material; EOPD; Early-onset Pompe disease; ERT; Enzyme replacement therapy; FEV1; Forced expirat
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Keywords: BiPAP; Bi-level positive airway pressure; CI; Confidence interval; CPAP; Continuous positive airway pressure; CRIM; Cross-reactive immunologic material; EKG; Electrocardiogram; GAA; α-Glucosidase; RR; Risk ratio; SD; Standard deviation;